https://stock.noler.com/us/stock/molekule-group-inc https://stock.noler.com/us/stock/molekule-group-inc/13f-holdings-corporate-securities https://stock.noler.com/us/stock/molekule-group-inc/accounts-payable https://stock.noler.com/us/stock/molekule-group-inc/accounts-receivable https://stock.noler.com/us/stock/molekule-group-inc/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/molekule-group-inc/accrued-liabilities-current https://stock.noler.com/us/stock/molekule-group-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/molekule-group-inc/accrued-salaries-current https://stock.noler.com/us/stock/molekule-group-inc/accumulated-depreciation https://stock.noler.com/us/stock/molekule-group-inc/acquisitions https://stock.noler.com/us/stock/molekule-group-inc/additional-paid-in-capital https://stock.noler.com/us/stock/molekule-group-inc/amended-reports https://stock.noler.com/us/stock/molekule-group-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/molekule-group-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/molekule-group-inc/auditor https://stock.noler.com/us/stock/molekule-group-inc/authorized-dilution https://stock.noler.com/us/stock/molekule-group-inc/basic-shares https://stock.noler.com/us/stock/molekule-group-inc/beta https://stock.noler.com/us/stock/molekule-group-inc/borrowing-debt https://stock.noler.com/us/stock/molekule-group-inc/buybacks-repurchase-programs https://stock.noler.com/us/stock/molekule-group-inc/capital-expenditures https://stock.noler.com/us/stock/molekule-group-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/molekule-group-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/molekule-group-inc/cash-and-equivalents https://stock.noler.com/us/stock/molekule-group-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/molekule-group-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/molekule-group-inc/cash-and-securities https://stock.noler.com/us/stock/molekule-group-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/molekule-group-inc/cash-flow-breakdown https://stock.noler.com/us/stock/molekule-group-inc/clinical-trials https://stock.noler.com/us/stock/molekule-group-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/molekule-group-inc/common-stock-value https://stock.noler.com/us/stock/molekule-group-inc/congressional-trades https://stock.noler.com/us/stock/molekule-group-inc/convertible-securities-outstanding https://stock.noler.com/us/stock/molekule-group-inc/convertible-securities-retired https://stock.noler.com/us/stock/molekule-group-inc/cost-of-goods-and-services-sold-depreciation-and-amortization https://stock.noler.com/us/stock/molekule-group-inc/cost-of-revenue https://stock.noler.com/us/stock/molekule-group-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/molekule-group-inc/current-assets https://stock.noler.com/us/stock/molekule-group-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/molekule-group-inc/current-liabilities https://stock.noler.com/us/stock/molekule-group-inc/customer-breakdown https://stock.noler.com/us/stock/molekule-group-inc/debt-and-obligation-disclosures https://stock.noler.com/us/stock/molekule-group-inc/deferred-compensation-arrangement-with-individual-allocated-share-based-compensation-expense https://stock.noler.com/us/stock/molekule-group-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/molekule-group-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/molekule-group-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/molekule-group-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/molekule-group-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-tax-credit-carryforwards-other https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-other https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-liabilities-deferred-expense-other-capitalized-costs https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-liabilities-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/molekule-group-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/molekule-group-inc/depreciation https://stock.noler.com/us/stock/molekule-group-inc/depreciation-and-amortization https://stock.noler.com/us/stock/molekule-group-inc/diluted-shares https://stock.noler.com/us/stock/molekule-group-inc/dividend-safety https://stock.noler.com/us/stock/molekule-group-inc/due-to-related-parties-current https://stock.noler.com/us/stock/molekule-group-inc/earnings-and-revenue-growth https://stock.noler.com/us/stock/molekule-group-inc/ebitda https://stock.noler.com/us/stock/molekule-group-inc/effective-tax-rate https://stock.noler.com/us/stock/molekule-group-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/molekule-group-inc/eps https://stock.noler.com/us/stock/molekule-group-inc/eps-basic https://stock.noler.com/us/stock/molekule-group-inc/executive-pay-measures https://stock.noler.com/us/stock/molekule-group-inc/executive-pay-other https://stock.noler.com/us/stock/molekule-group-inc/executive-pay-pvp https://stock.noler.com/us/stock/molekule-group-inc/executive-pay-trading-arrangements https://stock.noler.com/us/stock/molekule-group-inc/executive-salary-before-2006 https://stock.noler.com/us/stock/molekule-group-inc/executive-salary-board https://stock.noler.com/us/stock/molekule-group-inc/executive-salary-equity-awards https://stock.noler.com/us/stock/molekule-group-inc/executive-salary-officers https://stock.noler.com/us/stock/molekule-group-inc/executive-salary-other-compensation https://stock.noler.com/us/stock/molekule-group-inc/executive-salary-other-mentions https://stock.noler.com/us/stock/molekule-group-inc/executive-salary-pay-ratio https://stock.noler.com/us/stock/molekule-group-inc/executive-salary-relatives https://stock.noler.com/us/stock/molekule-group-inc/fails-to-deliver https://stock.noler.com/us/stock/molekule-group-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/molekule-group-inc/federal-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/molekule-group-inc/financing-cash-flow https://stock.noler.com/us/stock/molekule-group-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/molekule-group-inc/finite-lived-intangible-assets-amortization-expense-next-rolling-twelve-months https://stock.noler.com/us/stock/molekule-group-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-two https://stock.noler.com/us/stock/molekule-group-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/molekule-group-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/molekule-group-inc/form-d-other https://stock.noler.com/us/stock/molekule-group-inc/free-cash-flow https://stock.noler.com/us/stock/molekule-group-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/molekule-group-inc/general-and-administrative-expense https://stock.noler.com/us/stock/molekule-group-inc/goodwill https://stock.noler.com/us/stock/molekule-group-inc/gross-margin https://stock.noler.com/us/stock/molekule-group-inc/gross-profit https://stock.noler.com/us/stock/molekule-group-inc/holders-breakdown https://stock.noler.com/us/stock/molekule-group-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/molekule-group-inc/income-tax https://stock.noler.com/us/stock/molekule-group-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/molekule-group-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/molekule-group-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/molekule-group-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/molekule-group-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/molekule-group-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/molekule-group-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/molekule-group-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/molekule-group-inc/insider-holders https://stock.noler.com/us/stock/molekule-group-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/molekule-group-inc/insider-transactions-other https://stock.noler.com/us/stock/molekule-group-inc/insider-transactions-preferred https://stock.noler.com/us/stock/molekule-group-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/molekule-group-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/molekule-group-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/molekule-group-inc/insider-transactions-warrants https://stock.noler.com/us/stock/molekule-group-inc/institutional-holders https://stock.noler.com/us/stock/molekule-group-inc/interest-expense https://stock.noler.com/us/stock/molekule-group-inc/interest-paid-net https://stock.noler.com/us/stock/molekule-group-inc/inventory https://stock.noler.com/us/stock/molekule-group-inc/inventory-finished-goods https://stock.noler.com/us/stock/molekule-group-inc/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/molekule-group-inc/inventory-work-in-process https://stock.noler.com/us/stock/molekule-group-inc/investing-cash-flow https://stock.noler.com/us/stock/molekule-group-inc/iran-activity-notices https://stock.noler.com/us/stock/molekule-group-inc/late-filing-notices https://stock.noler.com/us/stock/molekule-group-inc/lawsuits-defendant https://stock.noler.com/us/stock/molekule-group-inc/lawsuits-plaintiff https://stock.noler.com/us/stock/molekule-group-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/molekule-group-inc/litigation-reserve https://stock.noler.com/us/stock/molekule-group-inc/long-term-notes-and-loans https://stock.noler.com/us/stock/molekule-group-inc/long-term-notes-payable https://stock.noler.com/us/stock/molekule-group-inc/major-holders https://stock.noler.com/us/stock/molekule-group-inc/material-contracts https://stock.noler.com/us/stock/molekule-group-inc/members-capital https://stock.noler.com/us/stock/molekule-group-inc/members-equity https://stock.noler.com/us/stock/molekule-group-inc/mentioned-by-other https://stock.noler.com/us/stock/molekule-group-inc/mutual-fund-holders https://stock.noler.com/us/stock/molekule-group-inc/net-income https://stock.noler.com/us/stock/molekule-group-inc/news https://stock.noler.com/us/stock/molekule-group-inc/notes-payable-current https://stock.noler.com/us/stock/molekule-group-inc/number-of-operating-segments https://stock.noler.com/us/stock/molekule-group-inc/obligation-breakdown https://stock.noler.com/us/stock/molekule-group-inc/operating-cash-flow https://stock.noler.com/us/stock/molekule-group-inc/operating-expenses https://stock.noler.com/us/stock/molekule-group-inc/operating-income https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-assets https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-cost https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-liability https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-liability-current https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-payments-due https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/molekule-group-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/molekule-group-inc/operating-margin https://stock.noler.com/us/stock/molekule-group-inc/other https://stock.noler.com/us/stock/molekule-group-inc/other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/molekule-group-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/molekule-group-inc/other-expenses https://stock.noler.com/us/stock/molekule-group-inc/other-income https://stock.noler.com/us/stock/molekule-group-inc/other-noncurrent-assets https://stock.noler.com/us/stock/molekule-group-inc/outstanding-bonds https://stock.noler.com/us/stock/molekule-group-inc/outstanding-bonds-foreign https://stock.noler.com/us/stock/molekule-group-inc/outstanding-bonds-matured https://stock.noler.com/us/stock/molekule-group-inc/outstanding-bonds-matured-foreign https://stock.noler.com/us/stock/molekule-group-inc/outstanding-bonds-matured-unclassified https://stock.noler.com/us/stock/molekule-group-inc/outstanding-bonds-unclassified https://stock.noler.com/us/stock/molekule-group-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/molekule-group-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/molekule-group-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/molekule-group-inc/partners-capital-account-units-sale-of-units https://stock.noler.com/us/stock/molekule-group-inc/patents https://stock.noler.com/us/stock/molekule-group-inc/patents-active https://stock.noler.com/us/stock/molekule-group-inc/patents-expired https://stock.noler.com/us/stock/molekule-group-inc/patents-pending https://stock.noler.com/us/stock/molekule-group-inc/patents-rejected https://stock.noler.com/us/stock/molekule-group-inc/payables-and-obligations https://stock.noler.com/us/stock/molekule-group-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/molekule-group-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/molekule-group-inc/pb-ratio https://stock.noler.com/us/stock/molekule-group-inc/pe-ratio https://stock.noler.com/us/stock/molekule-group-inc/preferred-shares https://stock.noler.com/us/stock/molekule-group-inc/preferred-shares-facts https://stock.noler.com/us/stock/molekule-group-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/molekule-group-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/molekule-group-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/molekule-group-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/molekule-group-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/molekule-group-inc/pretax-income https://stock.noler.com/us/stock/molekule-group-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/molekule-group-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/molekule-group-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/molekule-group-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/molekule-group-inc/proceeds-from-lease-payments https://stock.noler.com/us/stock/molekule-group-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/molekule-group-inc/product-warranty-accrual-classified-current https://stock.noler.com/us/stock/molekule-group-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/molekule-group-inc/property-plant-equipment https://stock.noler.com/us/stock/molekule-group-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/molekule-group-inc/ps-ratio https://stock.noler.com/us/stock/molekule-group-inc/public-float https://stock.noler.com/us/stock/molekule-group-inc/quick-ratio https://stock.noler.com/us/stock/molekule-group-inc/reddit https://stock.noler.com/us/stock/molekule-group-inc/repayments-of-other-debt https://stock.noler.com/us/stock/molekule-group-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/molekule-group-inc/research-and-development https://stock.noler.com/us/stock/molekule-group-inc/restricted-cash-current https://stock.noler.com/us/stock/molekule-group-inc/retained-earnings https://stock.noler.com/us/stock/molekule-group-inc/revenue https://stock.noler.com/us/stock/molekule-group-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/molekule-group-inc/sec-comment-letters https://stock.noler.com/us/stock/molekule-group-inc/sec-enforcement-actions https://stock.noler.com/us/stock/molekule-group-inc/sec-filings https://stock.noler.com/us/stock/molekule-group-inc/senior-long-term-notes https://stock.noler.com/us/stock/molekule-group-inc/sga-expense https://stock.noler.com/us/stock/molekule-group-inc/share-buybacks https://stock.noler.com/us/stock/molekule-group-inc/shareholder-equity https://stock.noler.com/us/stock/molekule-group-inc/shareholders-equity https://stock.noler.com/us/stock/molekule-group-inc/shares-authorized https://stock.noler.com/us/stock/molekule-group-inc/shares-issued https://stock.noler.com/us/stock/molekule-group-inc/shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/molekule-group-inc/shares-outstanding-analysis https://stock.noler.com/us/stock/molekule-group-inc/shares-subject-to-mandatory-redemption-settlement-terms-fair-value-of-shares https://stock.noler.com/us/stock/molekule-group-inc/short-interest https://stock.noler.com/us/stock/molekule-group-inc/short-sale-volume https://stock.noler.com/us/stock/molekule-group-inc/spending-and-interest-coverage https://stock.noler.com/us/stock/molekule-group-inc/standard-product-warranty-accrual https://stock.noler.com/us/stock/molekule-group-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/molekule-group-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/molekule-group-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/molekule-group-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/molekule-group-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/molekule-group-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/molekule-group-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/molekule-group-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/molekule-group-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/molekule-group-inc/stock-based-compensation https://stock.noler.com/us/stock/molekule-group-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/molekule-group-inc/stock-granted-value-share-based-compensation-gross https://stock.noler.com/us/stock/molekule-group-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/molekule-group-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/molekule-group-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/molekule-group-inc/stock-issued-shares-issued-value-stock-options-exercised-net-of-tax-benefit-expense https://stock.noler.com/us/stock/molekule-group-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/molekule-group-inc/subsidiaries https://stock.noler.com/us/stock/molekule-group-inc/supplier-breakdown https://stock.noler.com/us/stock/molekule-group-inc/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/molekule-group-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/molekule-group-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/molekule-group-inc/tax-rate-reconciliation-deductions-other https://stock.noler.com/us/stock/molekule-group-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/molekule-group-inc/tax-rate-reconciliation-tax-contingencies-other https://stock.noler.com/us/stock/molekule-group-inc/tax-rate-reconciliation-tax-contingencies-state-and-local https://stock.noler.com/us/stock/molekule-group-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/molekule-group-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/molekule-group-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/molekule-group-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/molekule-group-inc/total-assets https://stock.noler.com/us/stock/molekule-group-inc/total-liabilities https://stock.noler.com/us/stock/molekule-group-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/molekule-group-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/molekule-group-inc/voting-outcome https://stock.noler.com/us/stock/molekule-group-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/molekule-group-inc/youtube